Inside the Gender Identity Industry
In 2011, while the US and the world were riveted by headlines of a second mass shooting at Virginia tech, the meltdown at Fukushima nuclear plant, and the death of Moammar Gadhafi, something most Americans could never imagine, was playing out behind the scenes. Jon Stryker, heir to a medical fortune and founder of Arcus Foundation, an LGBT NGO generated by Stryker’s wealth, was building a powerful infrastructure to drive the normalization and institutionalization of, transgenderism, the first medical identity.
In 2014, Time Magazine published a cover photo and feature of actor Laverne Cox, a man posing as a woman. Cox was purportedly ushering in a “transgender tipping point”. He had obviously had multiple surgeries to change the appearance of his secondary sex characteristics and was dressed in culturally ascribed feminine attire; long hair, make-up, a dress and heels. Though Cox was to be exhibit “A” of a transgender tipping point, prior to this date, transgenderism was not at the forefront of most people’s minds, so there was nothing obvious that preceded that moment which would constitute a “tipping point” having been reached.
Yet, suddenly transgenderism was everywhere – as if something had been generating behind the scenes (there was). Six years later we have transgender celebrities, transgender athletes, transgender CEOs, transgender health coverage, transgender students, language that has emerged specific to these individuals, laws rearranging reality for the rest of the world to accommodate them, new school curriculums for children and adults, new medical protocols, hormone availability, chest binders, packers, youth gender clinics, camps, modeling agencies and beauty products, etc., all for a tiny fraction of the population with an issue that has no known medical cause. Transgenderism is the first “medical condition,” reported to cause intense body dysphoria for many (especially as it impacts children) that is simultaneously promoted as an identity and being celebrated throughout western cultures.
This is the first time in history that body dysphoria of any sort has been promoted as normal, positive and as a medical identity to celebrate, in what is shaping up to be a prolific Gender Identity industry. People who identify as transgender, young women who have had voluntary double mastectomies of their healthy breasts, are being used in corporate advertising, to sell everything from underwear to shaving cream. Behemoth Law and media conglomerates are creating amicus briefs and legal support guides to drive the normalization process. Lawyers are being trained world wide and global organizations built for the specific task of normalizing this medical identity.
Who profits? The obvious answer is the medical industrial complex, with life long patients needing drugs and surgeries, people who will suffer the consequences of these drugs and surgeries as they age. But the medical industrial complex is not the only industry invested in normalizing and preparing for the growth of medical identities. In 2011, while America was thinking about other things, Yvette Burton was brought to Arcus Foundation as its new chief executive officer. For over a decade, Burton had served as a managing global business development executive, business transformation strategist, and market development research director for IBM’s Sales and General Business Services divisions. She has also led IBM’s commercial strategy for global LGBT partnerships and advised numerous multinational companies on their internal and external outreach to the LGBT community.
Prior to Laverne Cox’s Time Cover announcement of a “transgender tipping point,” Arcus Foundation was driving the normalization of this new medical identity, under the banner of LGB civil rights, not only into our institutions, legal and political structures but also into the marketplace.
With the guidance of Arcus Foundation hundreds of companies have continued to expand inclusion for individuals identifying as transgender across corporate America. Currently more than 80 percent of the Fortune 500 have clear gender identity protections; two-thirds have transgender-inclusive healthcare coverage; hundreds have LGBTQ+ and Allies business resource groups and internal training efforts and of course there is the issue of public bathrooms.
In 2016 North Carolina attempted to hold onto to their sex-specific public restrooms. HRC, the Trans Lobby group, engaged 206 corporations worth trillions of dollars to roll back the states bill. The bill (HB2) called for the continued protection and safety of women and girls, via sex-specific bathrooms. The trans lobby was able to curry the favor of major corporations toward less than one percent of the population who desire to be seen as the opposite sex, who increasingly reject biological reality in favor of a political ideology causing untold harm across many western cultures.
We are witnessing the birth of an industry, one that rejects biological reality. If we continue to allow for this social engineering, we can expect other medical identities to emerge, identities that will need medical and technological interventions for life in order to exist. These identities will be protected by laws that are now being implemented, purportedly to protect feelings, but are in reality legally deconstructing biological sex and what it means to be human.
See here for a visual list of corporations investing in the normalization of a new medical identity and corporate investment in the Gender Identity industry.